Sources | Names Used |
---|---|
GDSC1000 | Linifanib |
CTRPv2 | linifanib |
PharmacoGx | linifanib |
Database | Identifier |
---|---|
Smiles: | Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1 |
Pubchem: | 11485656 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FBXO21 | GDSC1000 | pan-cancer | AAC | -0.3 | 1e-14 |
mRNA | RHOH | GDSC1000 | pan-cancer | AAC | -0.29 | 3e-08 |
mRNA | PFKM | GDSC1000 | pan-cancer | AAC | -0.29 | 2e-16 |
mRNA | POU2AF1 | GDSC1000 | pan-cancer | AAC | -0.28 | 5e-10 |
mRNA | MZB1 | GDSC1000 | pan-cancer | AAC | -0.27 | 4e-08 |
mRNA | NCKAP1 | GDSC1000 | pan-cancer | AAC | -0.27 | 5e-05 |
mRNA | IRF4 | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-09 |
mRNA | PIM2 | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-09 |
mRNA | CD48 | GDSC1000 | pan-cancer | AAC | -0.24 | 9e-07 |
mRNA | SNTB2 | GDSC1000 | pan-cancer | AAC | -0.24 | 1e-10 |